Stabilising biologics for vaccine production

Manufacturing Chemist

Volumn 82, Issue 9, 2011, Pages 32-34

  Scholz, Martin ^a   Altenhofen, Wolfram ^a  

^a LEUKOCARE AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ETHYLENE OXIDE; EXCIPIENT; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; POLYOL; VACCINE;

ARTICLE; BETA RADIATION; BIOTECHNOLOGY; COST CONTROL; DEVICE; DNA MODIFICATION; DRUG FORMULATION; DRUG STABILITY; DRUG STORAGE; EQUIPMENT DESIGN; FREEZE DRYING; GAMMA IRRADIATION; IMMUNIZATION; PREVENTIVE HEALTH SERVICE; PRODUCT SAFETY; VACCINE PRODUCTION;

EID: 81455155707     PISSN: 02624230     EISSN: None     Source Type: Trade Journal    
DOI: None     Document Type: Article

References (9)

1. Abdul-Fattah A.M. et al. Pharm Res. 2007, 24:715-27.
2. White D.O. and Fenner F.J. Medical Virology. 3rd ed., Academics, Orlando FI, 1987.
3. Crommelin D.J.A. and Sindelar R.D. Pharmaceutical Biotechnology: An introduction for pharmaceuticals and pharmaceutic scientists, 2nd ed. Taylor and Francis, New York, 2002.
4. Brandau D.T. et al. J Pharm Sci. 2003, 92:218-31.
5. Schwendeman S.P. et al. Proc. Natl. Acad. Sci. USA. 1995, 92:11234-38
6. Bolgiano B. et al. Dev- Biol. 2000, 103:51-9.
7. Garrison W.M. et al. Radiat. Res. 1962, 16:483-502.
8. Chang L. and Pikal M.J. Pharm Sci. 2009, 98:2886-908.
9. Clausi A.L. et al. J Pharm Sci. 2008, 97:2049-61.